Literature DB >> 19673617

Cell therapies for inflammatory bowel diseases.

Azucena Salas, Elena Ricart, Julián Panés.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19673617     DOI： 10.1586/egh.09.26

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN： 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  2 in total

1.  Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells.

Authors:  Kang Chao; Shenghong Zhang; Yun Qiu; Xiaoyong Chen; Xiaoran Zhang; Chuang Cai; Yanwen Peng; Ren Mao; Meirav Pevsner-Fischer; Shomron Ben-Horin; Eran Elinav; Zhirong Zeng; Baili Chen; Yao He; Andy Peng Xiang; Minhu Chen
Journal:  Stem Cell Res Ther       Date:  2016-08-11       Impact factor: 6.832

2.  Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse model.

Authors:  Yang Yu; Tianyu Zhao; Deqin Yang
Journal:  Exp Anim       Date:  2017-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.